Milo Frattini

11.9k citations
117 papers · 10.1k · 3 hit papers · h-index 40

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Genomics and Diagnostics

Papers in

    • Colorectal Cancer Treatments and Studies 23
    • HER2/EGFR in Cancer Research 4
    • Cancer Genomics and Diagnostics 4

Milo Frattini

112 papers receiving 9.9k citations

Milo Frattini's Hit Papers

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis 2010 · 1.8k citations
1.8k0+6+12Years since publication50010001.5k

Peers

Milo Frattini
Comparison fields: 5 of 68
  • Oncology 4.3k
  • Cancer Research 712
  • Genetics 241
  • Gastroenterology 156
  • Pathology and Forensic Medicine 311
Replace Francesca Molinari with:
Francesca Molinari Switzerland
Christian Frederick Meyer United States
Valentina Boni Spain
Robert Radinsky United States
Matthew Hiram Taylor United States
Youngchul Song United States
Katja Specht Germany
Alessio Amatu Italy
Todd Michael Bauer United States
Timothy Richard Wilson United States
Milo Frattini relative to Francesca Molinari Switzerland Francesca Molinari's profile →
Citations per field
00.5×1.5×1.8×
Francesca Molinari · 1×
Citations per year

Countries citing papers authored by Milo Frattini

Since Specialization
Citations

This map shows the geographic impact of Milo Frattini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milo Frattini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milo Frattini more than expected).

Fields of papers citing papers by Milo Frattini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milo Frattini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milo Frattini. The network helps show where Milo Frattini may publish in the future.

Co-authors

The 25 scholars most cited alongside Milo Frattini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Milo Frattini Line = papers co-authored together Milo Frattini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Hit paper breakdown →
20101821
2
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Hit paper breakdown →
20081371
3 2009649
4
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Hit paper breakdown →
2010637
5 2007462
6 2008359
7 2009321
8 2010320
9 2009232
10 2004226
11 2008187
12 2004185
13 2004159
14 2012150
15 2011144
16 2013133
17 2014126
18
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
2002122
19 2009115
20 2008112

About Milo Frattini

Milo Frattini is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 117 papers that have together received 10.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (23 papers), Lung Cancer Treatments and Mutations (8 papers), Genetic factors in colorectal cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Head and Neck Cancer Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (4.3k citations), Cancer Research (712 citations), Genetics (241 citations), Gastroenterology (156 citations) and Pathology and Forensic Medicine (311 citations). Milo Frattini has collaborated with scholars based in Switzerland, Italy and United States. Frequent co-authors include Francesca Molinari, Luca Mazzucchelli, Alberto Bardelli, Piercarlo Saletti, Federica Di Nicolantonio, Sara De Dosso, Salvatore Siena, Andrea Sartore Bianchi, Miriam Martini and Sabrina Arena. Their work appears in journals such as PLoS ONE, Clinical Cancer Research, British Journal of Cancer, Cancers and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact